BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 91.40
-4.00 (-4.19%)
At close: Feb 11, 2026
BIONET Market Cap
BIONET has a market cap or net worth of 4.6 billion as of February 13, 2026. Its market cap has increased by 10.28% in one year.
Market Cap
4.60B
Enterprise Value
4.18B
Revenue
1.22B
Ranking
n/a
PE Ratio
66.19
Stock Price
91.40
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 4.60B, an increase of 302.08%. That is a compound annual growth rate of 8.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.60B | -11.69% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Cenra | 4.96B |
| AnnJi Pharmaceutical | 4.88B |
| Senhwa Biosciences | 4.59B |
| BioGend Therapeutics | 4.58B |